Ignite Creation Date:
2024-05-05 @ 11:56 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00184522
Status:
COMPLETED
Last Update Posted:
2011-08-09
First Post:
2005-09-15
Brief Title:
On Demand Treatment of Reflux Disease
Sponsor:
Norwegian University of Science and Technology
Organization:
Norwegian University of Science and Technology
Study Overview
Official Title:
Aflurax Versus Nexium Given on Demand to Patients With Gastro-esophageal Reflux Disease
Status:
COMPLETED
Status Verified Date:
2005-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A comparison of the effect of on demand treatment with a pectin-containing natural product Aflurax with that esomeprazole Nexium
Detailed Description:
A randomized controlled open trial comparing the symptomatic effect of a pectin-containing product Aflurax with that of esomeprazole Nexium 20 mg given on-demand for 6 weeks
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None